Abdullatif Al Khedr
Amiens, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.
Journal: Annals of clinical and translational neurology
Published: June 12, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology
Published: May 05, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 28, 2026
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.
Journal: Neurology
Published: July 30, 2025
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 16, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 11, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study.
Journal: European journal of neurology
Published: May 07, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
Journal: JAMA neurology
Published: February 12, 2024
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 14, 2022
The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus.
Journal: Neurology and therapy
Published: October 25, 2022
Last Updated: 09/26/2026